Outcomes for split-thickness skin transplantation in high-risk XXXX using @entity31997 .

@entity1 @entity6 @entity39 @entity31997 @entity7298 @entity73 @entity228 @entity4279 @entity86 @entity446 @entity320
UNASSIGNED: Skin transplantation is a commonly used surgical technique; however, the complication rate, including @entity86 and delayed wound @entity446 due to inefficient perfusion, is significantly higher in @entity1 suffering from comorbidities. Hence, a subsequent repeat procedure is often necessary. In this report, two case studies are presented in which an @entity31997 -based antiseptic is used with a @entity7298 ( @entity7298 ) instead of @entity4279 ( @entity4279 ), following a split-thickness skin graft. The two @entity1 selected were deemed to be at high risk of @entity73 due to comorbidities. The first @entity1 , a confirmed smoker with @entity6 , presented with a @entity320 that was resected and covered with a split-thickness skin graft. After 5 days of negative pressure wound therapy as a @entity7298 , in combination with @entity4279 , the graft became @entity39 . A second split-thickness skin graft was performed and an antiseptic regimen with @entity31997 in combination with the same @entity7298 resulted in a completely healed transplant. The second @entity1 , also a confirmed smoker with @entity6 and receiving oral @entity228 treatment, was diagnosed with a @entity39 on her leg. Following the split-thickness skin graft, @entity31997 and @entity7298 were applied. The @entity1 's skin graft completely healed without any adverse events. These two case studies indicate that the combination of @entity31997 and @entity7298 following split-thickness skin transplantation is safe, well-tolerated and appears to have positive benefits in the reconstruction of defects in @entity1 with @entity73 .
